26.47% | % of shares held by all insiders |
27.38% | % of shares held by institutions |
37.24% | % of float held by institutions |
100 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Softbank Group Corporation | 5,681,818 | 31 Dec 2023 | 4.70% | 26,022,726 |
Laurion Capital Management, LP | 5,409,533 | 31 Dec 2023 | 4.47% | 24,775,660 |
Baillie Gifford and Company | 4,690,480 | 31 Dec 2023 | 3.88% | 21,482,398 |
Platinum Investment Management Ltd | 4,088,318 | 31 Dec 2023 | 3.38% | 18,724,496 |
Woodline Partners LP | 1,642,942 | 31 Dec 2023 | 1.36% | 7,524,674 |
Bill & Melinda Gates Foundation | 1,590,909 | 31 Dec 2023 | 1.32% | 7,286,363 |
MIC Capital Management UK LLP | 1,542,600 | 31 Dec 2023 | 1.28% | 7,065,107 |
Marshall Wace LLP | 1,300,068 | 31 Dec 2023 | 1.08% | 5,954,311 |
Nan Fung Group Holdings Limited | 859,892 | 31 Dec 2023 | 0.71% | 3,938,305 |
Pivotal bioVenture Partners Investment Advisor, LLC | 770,500 | 31 Dec 2023 | 0.64% | 3,528,889 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
iShares Biotechnology ETF | 727,272 | 31 Mar 2024 | 0.60% | 3,330,905 |
WisdomTree Tr-WisdomTree Artificial Intelligence & Innovation Fd | 185,301 | 29 Feb 2024 | 0.15% | 848,678 |
Goldman Sachs ETF Tr-Goldman Sachs Innovate Equity ETF | 39,582 | 31 Mar 2024 | 0.03% | 181,285 |
ETF Series Solutions-Range Cancer Therapeutics ETF | 32,092 | 29 Feb 2024 | 0.03% | 146,981 |
Baillie Gifford Health Innovation Equities Fund | 25,810 | 31 Dec 2023 | 0.02% | 118,209 |
Fidelity NASDAQ Composite Index Fund | 26,738 | 29 Feb 2024 | 0.02% | 122,460 |
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF | 24,648 | 29 Feb 2024 | 0.02% | 112,887 |
Themes ETF Tr-Themes Generative Artificial Intelligence ETF | 13,641 | 31 Dec 2023 | 0.01% | 62,475 |
ETFis Ser Tr I-Virtus LifeSci Biotech Clinical Trials ETF | 13,909 | 31 Jan 2024 | 0.01% | 63,703 |
ProShares Tr-Ultra Nasdaq Biotechnology Fd | 3,523 | 31 Mar 2024 | 0.00% | 16,135 |